Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-11-03Clinical Trial Update: Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer [Phase 3]
A Phase 3 trial comparing letrozole with lerociclib versus letrozole with placebo in advanced/metastatic or recurrent endometrial cancer was…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer [Phase 2]
A Phase 2 clinical trial investigating radiation therapy with Paclitaxel and Carboplatin in high-risk endometrial cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer [Phase 3]
Phase 3 trial evaluating molecular profile-based versus standard adjuvant radiotherapy in endometrial cancer; currently ACTIVE_NOT_RECRUITIN…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer [Phase 2]
Phase 2 trial investigating concurrent use of Lymphoseek and Indocyanine Green for sentinel lymph node detection in endometrial cancer; stud…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer [Phase 3]
A randomized Phase 3 trial evaluating radiation therapy with or without chemotherapy for endometrial cancer is in an unknown status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors [Phase 1]
Phase 1 results for a study combining the TORC1/2 inhibitor MLN0128 (sapanisertib) with bevacizumab in adults with recurrent glioblastoma or…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Sentinel Node in Endometrial Cancer [Phase 2]
Phase 2 clinical trial update investigating sentinel node mapping in endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial update of BKM120 as monotherapy for initial or recurrent metastatic endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial evaluating perifosine for metastatic or locally advanced soft tissue sarcoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial update for ridaforolimus in recurrent/metastatic and locally advanced endometrial cancer completes enrollment.
-
FDA approval · 2023-06-16FDA Approved: CARBOPLATIN — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for generic carboplatin. This action permits Apotex to market a generic carboplatin for…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma [Phase 2]
Phase 2 study of DKN-01 as a monotherapy or with paclitaxel in recurrent epithelial endometrial cancer, epithelial ovarian cancer, or carcin…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity [Phase 1, Phase 2]
Clinical trial exploring risk factors of immune checkpoint inhibitor–mediated liver, GI, endocrine, and skin toxicity across early-phase tri…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer [Phase 2]
Phase 2 trial evaluating carboplatin/paclitaxel with or without trastuzumab in uterine serous/endometrial cancer completed; results posted i…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer [Phase 3]
A Phase 3 clinical trial evaluating metformin's effects on fertility-sparing treatment for early endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: NR in Chemo-induced Peripheral Neuropathy [Phase 2]
Phase 2 trial update for NR in chemo-induced peripheral neuropathy shows termination with posted results.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating radiation therapy with or without cisplatin for recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: A Study to Assess the Efficacy and Safety of ABTL0812 [Phase 1, Phase 2]
Phase 1/2 trial evaluating ABTL0812 for endometrial cancer and squamous non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial of LY3023414 for recurrent or persistent endometrial cancer has completed; results posted in 2023.
-
FDA approval · 2023-02-09FDA Approved: JEMPERLI — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for JEMPERLI (dostarlimab) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) [Phase 1, Phase 2]
Open-label, dose-escalation study of pemigatinib in advanced malignancies (FIGHT-101) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of Enapotamab Vedotin in solid tumors, including ovarian and cervical cancer; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer [Phase 3]
Phase 3 trial evaluating short-course vaginal cuff brachytherapy for stage I–II endometrial cancer is currently recruiting. Results were pos…
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer [Phase 2]
A Phase 2 trial evaluating letrozole in combination with RAD001 (everolimus) for advanced or recurrent endometrial cancer; the study status …
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions [Phase 3]
Phase 3 trial evaluating molecular classification and traditional risk stratification to guide adjuvant radiotherapy decisions in early-stag…